🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. Metoprolol succinate

    United Therapeutics Europe Ltd

    Pulmonary Disease, Chronic Obstructive

    phase 3 small molecule terminated

    1 trial

  2. MiLES

    Turn Therapeutics

    Cancer

    phase 3 other active

    1 trial

  3. Mibavademab

    Regeneron UK Limited

    Generalized Lipodystrophy

    phase 3 small molecule active

    2 trials

  4. Mifepristone

    CORCEPT THERAPEUTICS INC

    Depressive Disorder, Major

    phase 3 small molecule completed

    1 trial

  5. Migalastat Hydrochloride Dispersible Tablet

    AMICUS THERAPEUTICS PTY LTD

    Fabry disease

    phase 3 small molecule active

    1 trial

  6. Mimetic granules of Yiqi-Wenjing prescriptions

    The First People's Hospital of Lianyungang

    Chemotherapy-induced Peripheral Neuropathy

    phase 3 small molecule active

    1 trial

  7. Mirabegron

    Astellas Pharma Inc

    Overactive Bladder (OAB)

    phase 3 small molecule terminated

    1 trial

  8. Mirabegron

    Astellas Pharma GmbH

    Neurogenic detrusor overactivity (NDO)

    phase 3 small molecule active

    1 trial

  9. Mirasol-treated Fresh Whole Blood

    United Therapeutics Europe Ltd

    Transfusion-Transmitted Infectious Disease

    phase 3 mab completed

    1 trial

  10. Mirikizumab

    Eli Lilly and Company

    Ulcerative Colitis

    phase 3 small molecule active

    2 trials

  11. Mirikizumab SC

    Eli Lilly and Company

    Ulcerative Colitis

    phase 3 small molecule completed

    1 trial

  12. Mirikizumab, Mirikizumab

    Eli Lilly Co.

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  13. Mirikizumab, Tirzepatide, to match Tirzepatide, Tirzepatide, Tirzepatide, Mirikizumab, Tirzepatide, Tirzepatide, Tirzepatide

    Eli Lilly Co.

    Obesity or Overweight, Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  14. Mitomycin-C

    United Therapeutics Europe Ltd

    Corneal Opacity

    phase 3 small molecule active

    1 trial

  15. Mixed salts of a single-entity amphetamine

    Takeda

    Attention Deficit Disorder With Hyperactivity

    phase 3 small molecule completed

    1 trial

  16. Mixed salts of a single-entity amphetamine (ADDERALL XR)

    Takeda

    ADHD

    phase 3 small molecule completed

    1 trial

  17. Modafinil

    Teva Pharma GmbH

    Attention Deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    3 trials

  18. Moxifloxacin

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease (COPD).

    phase 3 small molecule active

    1 trial

  19. NDV-01 (sustained-release gemcitabine-docetaxel)

    RELMADA THERAPEUTICS, INC.

    Bladder (Urothelial, Transitional Cell) Cancer

    phase 3 small molecule active

    2 trials

  20. NDV-01 (sustained-release gemcitabine-docetaxel)

    RELMADA THERAPEUTICS, INC.

    Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)

    phase 3 small molecule terminated

    1 trial

  21. NEORAL® Soft Gelatin Capsules 100mg, Methotrexate 2.5 mg Tablets, Zilbrysq 16.6 mg solution for injection in pre-filled syringe, Prednisolone 5mg Tablets, Azathioprine Tablets 50mg Oprisine, Privigen 100 mg/ml solution for infusion, Soliris 300 mg concentrate for solution for infusion, Methotrexate 2.5 mg Tablets, NEORAL® Soft Gelatin Capsules 50mg, Methotrexate 2.5 mg Tablets, NEORAL® Soft Gelatin Capsules 10mg, Methotrexate 2.5 mg Tablets, Methotrexate 2.5 mg Tablets, NEORAL® Soft Gelatin Capsules 25mg, K

    Kyverna Therapeutics

    Generalized myasthenia gravis

    phase 3 small molecule active

    1 trial

  22. NFC-1

    Avalo Therapeutics

    Attention Deficit Disorder With Hyperactivity

    phase 3 small molecule completed

    1 trial

  23. NIVOLUMAB, GEMCITABINE, TEPMETKO 225 mg film-coated tablets, PACLITAXEL, DOCETAXEL, ATEZOLIZUMAB, BEVACIZUMAB, PEMBROLIZUMAB, VINORELBINE, PEMETREXED

    CERO THERAPEUTICS HOLDINGS, INC.

    Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  24. NKTR-102

    Nektar Therapeutics UK Limited

    Metastasis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources